Free Trial

Molecular Templates (MTEM) SEC Filings & 10K Form

$1.28
-0.04 (-3.03%)
(As of 05/24/2024 ET)

Recent Molecular Templates SEC Filings

DateFilerForm TypeView
05/15/2024
4:18 PM
Molecular Templates (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2024
4:21 PM
Molecular Templates (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/05/2024
11:15 PM
Molecular Templates (Filer)
Form EFFECT
04/29/2024
8:51 PM
Longitude Capital Partners III, LLC (Filed by)
Molecular Templates (Subject)
Form SC 13D/A
04/25/2024
3:33 PM
Molecular Templates (Filer)
Form S-3
Registration statement under Securities Act of 1933  
04/12/2024
3:22 PM
Molecular Templates (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/04/2024
7:13 PM
BB BIOTECH AG (Reporting)
BIOTECH TARGET N V (Reporting)
Molecular Templates (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/04/2024
3:57 PM
LALANDE KEVIN M. (Reporting)
Molecular Templates (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2024
8:56 PM
Molecular Templates (Subject)
SANTE HEALTH VENTURES I LP (Filed by)
Form SC 13D/A
03/29/2024
3:06 PM
Molecular Templates (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/29/2024
7:57 AM
Molecular Templates (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/29/2024
7:45 AM
Molecular Templates (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/28/2024
7:22 AM
Molecular Templates (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/15/2024
3:08 PM
Molecular Templates (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2024
7:39 PM
Molecular Templates (Subject)
SILVERARC CAPITAL MANAGEMENT, LLC (Filed by)
Form SC 13G
02/14/2024
3:45 PM
K2 HealthVentures Equity Trust LLC (Filed by)
Molecular Templates (Subject)
Form SC 13G/A
02/14/2024
8:33 AM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Molecular Templates (Subject)
Form SC 13G/A
02/13/2024
10:00 AM
BB BIOTECH AG (Filed by)
Molecular Templates (Subject)
Form SC 13G/A
01/25/2024
4:32 PM
Molecular Templates (Issuer)
Poma Eric E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2024
4:34 PM
Kim Jason S. (Reporting)
Molecular Templates (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2024
4:49 PM
Molecular Templates (Issuer)
Voi Maurizio (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/31/2023
5:45 PM
LALANDE KEVIN M. (Reporting)
Molecular Templates (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/31/2023
5:46 PM
Lanfear Jonathan (Reporting)
Molecular Templates (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/31/2023
5:46 PM
Molecular Templates (Issuer)
Sanders Corazon D. (0001796536) (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/31/2023
5:46 PM
Molecular Templates (Issuer)
SELICK HAROLD E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/31/2023
5:45 PM
Gruia Gabriela (Reporting)
Molecular Templates (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/31/2023
5:45 PM
HOFFMANN DAVE (Reporting)
Molecular Templates (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/27/2023
3:12 PM
Molecular Templates (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/06/2023
4:08 PM
Molecular Templates (Issuer)
Voi Maurizio (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/28/2023
4:01 PM
Molecular Templates (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/12/2023
4:08 PM
Molecular Templates (Filer)
Form DEF 14A
09/12/2023
4:12 PM
Molecular Templates (Filer)
Form DEFA14A
09/12/2023
4:15 PM
Molecular Templates (Filer)
Form ARS
08/31/2023
5:22 PM
Gruia Gabriela (Reporting)
Molecular Templates (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2023
11:15 PM
Molecular Templates (Filer)
Form EFFECT
08/10/2023
8:01 AM
Molecular Templates (Filer)
Form S-3
Registration statement under Securities Act of 1933  
08/10/2023
7:18 AM
Molecular Templates (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/10/2023
7:09 AM
Molecular Templates (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/20/2023
4:09 PM
LYTTON LAURENCE W (Filed by)
Molecular Templates (Subject)
Form SC 13G
07/19/2023
2:14 PM
BB BIOTECH AG (Reporting)
BIOTECH TARGET N V (Reporting)
Molecular Templates (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2023
2:05 PM
ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
Molecular Templates (Subject)
Form SC 13G
[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks (Ad)

Did you see bitcoin crossed $70k again? Don't miss the next bull run. Because while Bitcoin and Ethereum steal all the headlines… It’s often the cryptos flying under the radar that turn small stakes into life-changing windfalls.

Claim your free seat by clicking here now.
07/18/2023
10:56 AM
Molecular Templates (Filer)
Form DEF 14A
07/13/2023
11:48 AM
Molecular Templates (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/30/2023
3:31 PM
Molecular Templates (Filer)
Form PRE 14A
06/26/2023
4:27 PM
K2 HealthVentures Equity Trust LLC (Filed by)
Molecular Templates (Subject)
Form SC 13G
06/20/2023
6:00 AM
Molecular Templates (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/01/2023
6:59 AM
Molecular Templates (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/26/2023
4:16 PM
Molecular Templates (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:MTEM) was last updated on 5/24/2024 by MarketBeat.com Staff

From Our Partners